CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +20,000 | $5.35 | $107K | 470,219 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,899 | $113.37 | $555K | 465,320 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −9,627 | $114.28 | $1.1M | 455,693 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,474 | $114.98 | $629K | 450,219 |
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 238,717 | ||
| 2024-10-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 218,717 | ||
| 2024-10-01 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +8,000 | $2.42 | $19K | 208,646 |
| 2024-10-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,312 | $113.42 | $262K | 206,334 |
| 2024-10-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −3,349 | $114.32 | $383K | 202,985 |
| 2024-10-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,339 | $114.95 | $269K | 200,646 |
| 2024-10-01 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 34,638 | ||
| 2024-10-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +5,500 | $21.41 | $118K | 34,123 |
| 2024-10-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,414 | $113.38 | $160K | 32,709 |
| 2024-10-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −3,056 | $114.37 | $350K | 29,653 |
| 2024-10-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,030 | $115.01 | $118K | 28,623 |
| 2024-10-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −5,500 | 174,497 | ||
| 2024-09-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 98,383 |
| 2024-09-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −5,485 | $115.60 | $634K | 92,898 |
| 2024-09-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −1,686 | $116.29 | $196K | 91,212 |
| 2024-09-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −829 | $117.53 | $97K | 90,383 |
Page 21 of 39 · 764 trades